Pioglitazone safe and effective for treating T2DM in patients with NASH

被引:0
作者
Tim Geach
机构
关键词
D O I
10.1038/nrendo.2016.113
中图分类号
学科分类号
摘要
引用
收藏
页码:498 / 498
相关论文
共 50 条
[21]   Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients [J].
Yan, Xueyu ;
Si, Jinglei ;
Zhong, Fangjie ;
Wu, Yanjun ;
Jiang, Qinyang ;
Guo, Yafen ;
Yang, Xiurong ;
Liang, Jing ;
Lan, Ganqiu .
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (02) :236-244
[22]   Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients [J].
Xueyu Yan ;
Jinglei Si ;
Fangjie Zhong ;
Yanjun Wu ;
Qinyang Jiang ;
Yafen Guo ;
Xiurong Yang ;
Jing Liang ;
Ganqiu Lan .
International Journal of Diabetes in Developing Countries, 2022, 42 :236-244
[23]   NASH: Pioglitazone is effective in Patients with and without Diabetes [J].
Bitzer, Michaela .
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (07)
[24]   T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients [J].
Thummasorn, Savitree ;
Apichai, Sopida ;
Chupradit, Supat ;
Sirisattayawong, Pornpen ;
Chaiwong, Pachpilai ;
Sriwichaiin, Sirawit ;
Pratchayasakul, Wasana ;
Chattipakorn, Nipon ;
Chattipakorn, Siriporn C. .
PLOS ONE, 2022, 17 (08)
[25]   Treating T2DM by ensuring insulin access is a global challenge [J].
Horlyck-Romanovsky, Margrethe F. ;
Sumner, Anne E. .
NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (03) :135-137
[26]   Effect of Liver Fat Accumulation on Insulin Resistance and Severity of NASH in Obese Patients with T2DM [J].
Lomonaco, Romina ;
Orsak, Beverly ;
Ortiz-Lopez, Carolina ;
Chan, Janet ;
Webb, Amy ;
Cusi, Kenneth .
DIABETES, 2011, 60 :A454-A454
[27]   PROGRAM ACTIVE II: TREATING MAJOR DEPRESSION IN T2DM [J].
de Groot, Mary ;
Hornsby, Guy ;
Saha, Chandan K. ;
Pillay, Yegan ;
Fitzpatrick, Karen ;
Mather, Kieren ;
Shubrook, Jay .
ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 :S1064-S1065
[28]   BUDGET IMPACT ANALYSIS OF VILDAGLIPTIN TREATING T2DM IN CHINA [J].
Fan, C. S. ;
Guan, H. J. ;
Wang, Y. N. .
VALUE IN HEALTH, 2016, 19 (03) :A200-A200
[29]   Treating T2DM by ensuring insulin access is a global challenge [J].
Margrethe F. Horlyck-Romanovsky ;
Anne E. Sumner .
Nature Reviews Endocrinology, 2019, 15 :135-137
[30]   Clinical inertia—a barrier to effective management of T2DM [J].
Julie A. Lovshin ;
Bernard Zinman .
Nature Reviews Endocrinology, 2013, 9 :635-636